With Some Help Small Canadian Biotech Could Challenge Roche's Hold in Stroke Treatment

Retrieved on: 2022-07-29 16:11:38

Tags for this article:

Click the tags to see associated articles and topics

With Some Help Small Canadian Biotech Could Challenge Roche's Hold in Stroke Treatment. View article details on hiswai:

Excerpt

NervGen showed that its proprietary drug NVG-291-R could repair the nervous system after a stroke—even when it was given up to seven days after ...

Article found on: www.biospace.com